tiprankstipranks
Novo Nordisk (GB:0QIU)
LSE:0QIU

Novo Nordisk (0QIU) Cash flow

23 Followers

Novo Nordisk Cash Flow

GB:0QIU's free cash flow for Q4 2023 was kr-6.88B. For the 2023 fiscal year, GB:0QIU's free cash flow was decreased by kr5.88B and operating cash flow was kr9.55B. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr 63.60Bkr 108.91Bkr 78.89B-kr 51.95Bkr 46.78B
Investing Cash Flow
kr -26.32Bkr -43.89Bkr -24.92B-kr -22.44Bkr -11.51B
Financing Cash Flow
kr -45.30Bkr -63.16Bkr -51.80B-kr -32.24Bkr -35.48B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 42.85Bkr 14.39Bkr 12.65B-kr 12.23Bkr 15.41B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
kr -863.00Mkr -1.47Bkr -2.41B-kr 5.68Bkr 81.00M
Repayment Of Debt
kr -1.13Bkr -1.47Bkr -13.62B-kr -950.00Mkr -822.00M
Free Cash Flow
kr 38.14Bkr 70.01Bkr 64.13B-kr 29.87Bkr 35.55B
Domestic Sales
------
Foreign Sales
------
Currency in DKK

Novo Nordisk Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis